CareDx, Inc

NASDAQ:CDNA

Medical - Diagnostics & Research

Healthcare
$74.44 +5.07%

+$1.19 today

Market cap
$3.91B
Beta
2.48
P/E (TTM)
-154.0
EPS (TTM)
-$0.16
52W Low $10.96High $24.96

Volume 0.54M

Average 0.74M

CDNA Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

CareDx, IncNASDAQ: CDNA

Weighted Avg Shares · Q2 FY2026 · quarter ended Jun 2026

Weighted avg shares declines year over year

Q2 FY2026 weighted avg shares of 51.47M shares fell 5.2% year over year, in line with the -4.8% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 0.6% from the prior quarter. Over 3 fiscal years it compounded at -0.0% a year.

Context

  • Weighted avg shares increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from -5.2% toward the trailing-twelve-month pace of -4.8%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
51.47M+0.6% QoQ
Last fiscal yearDec 2025
53.29M+1.0% YoY
LTMJun 2026
51.56M-4.8% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-5.2%——
1 year+1.0%——
3-year CAGR-0.0%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
53.29M USD
Year-over-year change
+1.0%
4-year CAGR
+0.5%

Weighted Avg Shares vs competitors

How CDNA compares with its peers on the latest reported figures

  • CDNA's LTM Jun 2026 weighted avg shares of 51.56M shares is the 5th highest of the 8 companies compared; the peer median is 79.27M shares.
  • Its year-over-year change of -4.8% is the lowest of 8, against a peer median of +2.2%.
  • Over three fiscal years its annual growth of -0.0% compares with a peer median of +4.1%.
CDNA Competitors Peer median
Weighted Avg Shares for CDNA and competitors
Company Period LTM YoY 3-year CAGR
QGENQiagen N.V.LTM Jun 2026209.5M -4.1%-2.0%
NTRANatera, Inc.LTM Jun 2026139.67M +7.5%+11.6%
MYGNMyriad Genetics, Inc.LTM Mar 202693.15M +2.4%+5.0%
VCYTVeracyte, Inc.LTM Jun 202679.27M +2.0%+3.2%
CDNACareDx, IncLTM Jun 202651.56M -4.8%-0.0%
BLLNBillionToOne, Inc.LTM Jun 202645.72M +2.2%—
FLGTFulgent Genetics, Inc.LTM Mar 202630.81M +1.0%+0.7%
WGSGeneDx Holdings Corp.LTM Jun 202628.68M +3.5%+38.0%
Peer median (excluding CDNA) 79.27M+2.2%+4.1%

Competitors are the stored peer set for CDNA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue296.4M321.79M280.32M333.79M379.81M
Cost of Revenue97.39M112.21M102M109.63M123.24M
Gross Profit199.01M209.58M178.33M224.16M256.57M
Gross Margin67.1%65.1%63.6%67.2%67.6%
Research & Development76.53M90.39M81.87M72.41M71.43M
Selling, General & Admin152.21M196.42M201.2M205.5M210.21M
Operating Expenses228.73M286.81M381.69M183.39M281.64M
Depreciation & Amortization11.89M16.01M19.82M19.76M20.42M
EBITDA(20.2M)(60.23M)(84.92M)(34M)(4.66M)
EBITDA Margin-6.8%-18.7%-30.3%-10.2%-1.2%
Operating Income(29.73M)(77.23M)(203.36M)40.77M(25.07M)
Operating Margin-10.0%-24.0%-72.5%12.2%-6.6%
Interest Income160K3.76M11.87M11.77M9.17M
Interest Expense00000
Other Income / Expenses(2.36M)997K13.22M12.09M3.99M
Income Before Tax(32.09M)(76.23M)(190.14M)52.86M(21.08M)
Pre-Tax Margin-10.8%-23.7%-67.8%15.8%-5.6%
Income Tax Expense(1.43M)379K141K310K271K
Net Income(30.66M)(76.61M)(190.28M)52.55M(21.35M)
Net Margin-10.3%-23.8%-67.9%15.7%-5.6%
EPS (Basic)(0.59)(1.44)(3.54)1.00(0.40)
EPS (Diluted)(0.59)(1.44)(3.54)0.93(0.40)
Weighted Avg Shares52.24M53.32M53.76M52.77M53.29M
Weighted Avg Shares (Diluted)52.24M53.32M53.76M56.62M53.29M

CareDx, Inc

NASDAQ:CDNA

Intrinsic Alpha fair value

Locked

Current Price

$74.44

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.